Cargando…

A radiomic biomarker for prognosis of resected colorectal cancer liver metastases generalizes across MRI contrast agents

INTRODUCTION: Contrast-enhanced MRI is routinely performed as part of preoperative work-up for patients with Colorectal Cancer Liver Metastases (CRLM). Radiomic biomarkers depicting the characteristics of CRLMs in MRI have been associated with overall survival (OS) of patients, but the reproducibili...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Jianan, Cheung, Helen M. C., Karanicolas, Paul J., Coburn, Natalie G., Martel, Guillaume, Lee, Albert, Patel, Chirag, Milot, Laurent, Martel, Anne L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9932499/ https://www.ncbi.nlm.nih.gov/pubmed/36816920 http://dx.doi.org/10.3389/fonc.2023.898854

Ejemplares similares

Delayed tumour enhancement on gadoxetate-enhanced MRI is associated with overall survival in patients with colorectal liver metastases
por: Cheung, Helen M. C., et al.
Publicado: (2018)

Late gadolinium enhancement of colorectal liver metastases post-chemotherapy is associated with tumour fibrosis and overall survival post-hepatectomy
por: Cheung, Helen M. C., et al.
Publicado: (2018)

Radiomics of liver MRI predict metastases in mice
por: Becker, Anton S., et al.
Publicado: (2018)

PET/MRI Radiomics in Patients With Brain Metastases
por: Lohmann, Philipp, et al.
Publicado: (2020)

Image Contrast, Image Pre-Processing, and T(1) Mapping Affect MRI Radiomic Feature Repeatability in Patients with Colorectal Cancer Liver Metastases
por: McHugh, Damien J., et al.
Publicado: (2021)

Prognostic Value of CT Radiomic Features in Resectable Pancreatic Ductal Adenocarcinoma
por: Khalvati, Farzad, et al.
Publicado: (2019)

Liver Resection for Non-Colorectal, Non-Carcinoid, Non-Sarcoma Metastases: A Multicenter Study
por: Martel, Guillaume, et al.
Publicado: (2015)

Prediction of Prognosis in Glioblastoma Using Radiomics Features of Dynamic Contrast-Enhanced MRI
por: Pak, Elena, et al.
Publicado: (2021)

Mn-Based MRI Contrast Agents: An Overview
por: Henoumont, Céline, et al.
Publicado: (2023)

MRI contrast agents: from molecules to particles
por: Laurent, Sophie, et al.
Publicado: (2017)

THE ERA OF MANAGEMENT OF COLORECTAL LIVER METASTASES
por: Martel, Gareth, et al.
Publicado: (2020)

Chemokine receptor 4 targeted protein MRI contrast agent for early detection of liver metastases
por: Tan, Shanshan, et al.
Publicado: (2020)

Contrast agents for hepatic MRI
por: Morana, Giovanni, et al.
Publicado: (2007)

MRI Contrast Agents in Glycobiology
por: Geraldes, Carlos F. G. C., et al.
Publicado: (2022)

Radiomics Analysis of Multiparametric MRI for Prediction of Synchronous Lung Metastases in Osteosarcoma
por: Luo, Zhendong, et al.
Publicado: (2022)

Improving prognostic performance in resectable pancreatic ductal adenocarcinoma using radiomics and deep learning features fusion in CT images
por: Zhang, Yucheng, et al.
Publicado: (2021)

Simultaneous resection of colorectal cancer with synchronous liver metastases (RESECT), a pilot study
por: Serrano, Pablo E., et al.
Publicado: (2018)

The Impact of Resampling and Denoising Deep Learning Algorithms on Radiomics in Brain Metastases MRI
por: Moummad, Ilyass, et al.
Publicado: (2021)

The Application of DTCWT on MRI-Derived Radiomics for Differentiation of Glioblastoma and Solitary Brain Metastases
por: Wu, Wen-Feng, et al.
Publicado: (2022)

An MRI-based radiomics nomogram for differentiating spinal metastases from multiple myeloma
por: Zhang, Shuai, et al.
Publicado: (2023)

Contrast-enhanced synthetic MRI for the detection of brain metastases
por: Hagiwara, Akifumi, et al.
Publicado: (2016)

MRI Contrast Agents for Pharmacological Research
por: Terreno, Enzo, et al.
Publicado: (2015)

Magnetic Nanomaterials as Contrast Agents for MRI
por: Caspani, Sofia, et al.
Publicado: (2020)

Magnetic Nanoparticles as MRI Contrast Agents
por: Avasthi, Ashish, et al.
Publicado: (2020)

Contrast MR-Based Radiomics and Machine Learning Analysis to Assess Clinical Outcomes following Liver Resection in Colorectal Liver Metastases: A Preliminary Study
por: Granata, Vincenza, et al.
Publicado: (2022)

Ipsilateral Recurrence of DCIS in Relation to Radiomics Features on Contrast Enhanced Breast MRI
por: Park, Ga Eun, et al.
Publicado: (2022)

MRI-based multiregional radiomics for predicting lymph nodes status and prognosis in patients with resectable rectal cancer
por: Li, Hang, et al.
Publicado: (2023)

Non-Contrasted CT Radiomics for SAH Prognosis Prediction
por: Shan, Dezhi, et al.
Publicado: (2023)

MRI-based Radiomics nomogram to detect primary rectal cancer with synchronous liver metastases
por: Shu, Zhenyu, et al.
Publicado: (2019)

Differentiation of Glioblastoma and Brain Metastases by MRI-Based Oxygen Metabolomic Radiomics and Deep Learning
por: Stadlbauer, Andreas, et al.
Publicado: (2022)

Hepatic metastases of hemangiopericytoma: contrast-enhanced MRI, contrast-enhanced ultrasonography and angiography findings
por: Aliberti, Camillo, et al.
Publicado: (2006)

Correction to: Magnetic Nanoparticles as MRI Contrast Agents
por: Avasthi, Ashish, et al.
Publicado: (2021)

Cyclodextrins: promising scaffolds for MRI contrast agents
por: Sembo-Backonly, Berthe Sandra, et al.
Publicado: (2021)

Radiomics analysis of contrast-enhanced T1W MRI: predicting the recurrence of acute pancreatitis
por: Tang, Lingling, et al.
Publicado: (2023)

Radiomics-based aortic flow profile characterization with 4D phase-contrast MRI
por: Huellebrand, Markus, et al.
Publicado: (2023)

Glycosaminoglycans and Contrast Agents: The Role of Hyaluronic Acid as MRI Contrast Enhancer
por: Ponsiglione, Alfonso Maria, et al.
Publicado: (2020)

Standardization of brain MR images across machines and protocols: bridging the gap for MRI-based radiomics
por: Carré, Alexandre, et al.
Publicado: (2020)

Radiomics-Derived Data by Contrast Enhanced Magnetic Resonance in RAS Mutations Detection in Colorectal Liver Metastases
por: Granata, Vincenza, et al.
Publicado: (2021)

Radiomics for pseudoprogression prediction in high grade gliomas: added value of MR contrast agent
por: Mammadov, Orkhan, et al.
Publicado: (2022)

MRI-Based Risk Assessment for Incomplete Resection of Brain Metastases
por: Rosenstock, Tizian, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_4jrt861t3lftidm8ifjpf3ui0o